We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Events

09 Apr 2024 - 12 Apr 2024
15 Apr 2024 - 17 Apr 2024
23 Apr 2024 - 26 Apr 2024

Biomarker of Kidney Disease Identified in Sickle Cell Anemia

By LabMedica International staff writers
Posted on 27 Dec 2017
Print article
Image: A histopathology of a fatal sickle cell crisis which resulted from sickling within the vasa recta within the kidney. Glomeruli are occluded by sickle cells (Photo courtesy of Dr. Vishai Ramteke).
Image: A histopathology of a fatal sickle cell crisis which resulted from sickling within the vasa recta within the kidney. Glomeruli are occluded by sickle cells (Photo courtesy of Dr. Vishai Ramteke).
In patients with sickle cell anemia (SCA), urinary ceruloplasmin (CP) may complement urinary free hemoglobin as a noninvasive biomarker for chronic kidney disease. Ceruloplasmin is a ferrioxidase that is important facilitator of cellular iron export by ferroportin and of iron binding by transferrin.

Hemolysis, vaso-occlusion, and ischemia-reperfusion injury are the clinical hallmarks of sickle cell disease (SCD). The renal manifestations of SCD range from various tubular and glomerular functional abnormalities to gross anatomic alterations of the kidneys. Chronic kidney disease (CKD) is a prevalent complication of sickle cell disease (SCD) and associated with early mortality. Hemoglobinuria is a risk factor for the development and progression of CKD.

Clinical scientists at the Howard University College of Medicine (Washington, DC, USA) conducted mass-spectrometry proteomic analysis on urine samples from patients with SCA and hemoglobinuria and six samples with high hemoglobin were compared to SCA control samples.

The team found that of 270 proteins that were initially identified, they researchers found that 48 were significantly up- or down-regulated in the samples with hemoglobinuria (P<0.0001). Subsequently, 18 extracellular proteins were focused on, including CP, a protein involved in iron metabolism. In SCA samples with hemoglobinuria, CP was present at much higher levels than that seen in SCA controls (P=1.8 × 10 −5).

The authors concluded that despite the increased urinary levels of ceruloplasmin, transferrin, and ferritin in the urine of SCA patients, only urinary CP demonstrated overall good correlations with chronic kidney disease (CKD) stage and urinary hemoglobin levels and represents a plausible noninvasive biomarker of CKD risk in SCA patients. The study was published on November 27, 2017, in the American Journal of Hematology.

Related Links:
Howard University College of Medicine

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
HLX
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
New
Gold Member
Plasma Control
Plasma Control Level 1

Print article

Channels

Molecular Diagnostics

view channel
Image: MOF materials efficiently enrich cfDNA and cfRNA in blood through simple operational process (Photo courtesy of Science China Press)

Blood Circulating Nucleic Acid Enrichment Technique Enables Non-Invasive Liver Cancer Diagnosis

The ability to diagnose diseases early can significantly enhance the effectiveness of clinical treatments and improve survival rates. One promising approach for non-invasive early diagnosis is the use... Read more

Hematology

view channel
Image: The low-cost portable device rapidly identifies chemotherapy patients at risk of sepsis (Photo courtesy of 52North Health)

POC Finger-Prick Blood Test Determines Risk of Neutropenic Sepsis in Patients Undergoing Chemotherapy

Neutropenia, a decrease in neutrophils (a type of white blood cell crucial for fighting infections), is a frequent side effect of certain cancer treatments. This condition elevates the risk of infections,... Read more

Pathology

view channel
Image: The OvaCis Rapid Test discriminates benign from malignant epithelial ovarian cysts (Photo courtesy of INEX)

Intra-Operative POC Device Distinguishes Between Benign and Malignant Ovarian Cysts within 15 Minutes

Ovarian cysts represent a significant health issue for women globally, with up to 10% experiencing this condition at some point in their lives. These cysts form when fluid collects within a thin membrane... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.